Selected Quarterly Financial Data (unaudited) - Summary of Selected Quarterly Financial Data (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Condensed Financial Statements, Captions [Line Items]
Additional paid-in-capital	$ 187,122	$ 172,575
Accumulated deficit	155,362	133,427
Research and development expenses	11,999	25,680
General and administrative Expenses	10,728	14,881
Total operating expenses	22,727	40,561
Net income (loss)	$ (21,935)	$ (39,276)
Weighted average shares used to compute net loss per share, basic	6,275,856	4,025,489
Weighted average shares used to compute net loss per share, diluted	6,275,856	4,025,489
Net loss per share, basic	$ (3.5)	$ (9.76)
Net loss per share, diluted	$ (3.5)	$ (9.76)